A STUDY TO ASSESS THE EFFECTIVENESS OF SELF-INSTRUCTIONAL MODULE ON KNOWLEDGE AND PRACTICE REGARDING PERIPHERAL INTRAVENOUS CATHETERIZATION AMONG NURSING STAFFS OF R.B.MEMORIAL HOSPITAL BIHAR

Dr. Manoj Kumar Sharma, Dr. Bimla Rani rani
{"title":"A STUDY TO ASSESS THE EFFECTIVENESS OF SELF-INSTRUCTIONAL MODULE ON KNOWLEDGE AND PRACTICE REGARDING PERIPHERAL INTRAVENOUS CATHETERIZATION AMONG NURSING STAFFS OF R.B.MEMORIAL HOSPITAL BIHAR","authors":"Dr. Manoj Kumar Sharma, Dr. Bimla Rani rani","doi":"10.47211/tg.2022.v09i01.008","DOIUrl":null,"url":null,"abstract":"Peripheral intravenous catheters (PIVC) are the most commonly used intravenous device in hospital emergency departments and inpatient units. They are primarily used for therapeutic purposes such as administration of medications, fluids and/or blood products as well as blood sampling. Unsuccessful PIVC first attempts increase pain, and lead to treatment and diagnostic delays. Traditionally, PIVC involves vein and equipment selection before catheterization. Clinicians select peripheral veins based upon vein palpability and visibility, and may use vein stimulation, limb positioning, tourniquets or other techniques to improve first attempt success. There has been an increasing concern among health professional and the general public about HCAI. HCAI is a major cause of morbidity and mortality every year and up to 8.5% of hospitalized patient suffer from HCAI. In a national and multicenter studies reported, it was identified that the prevalence of hospitalized patients who acquired at least one HCAI ranged from 3.5% to 12%. This increasing concern in number of HCAI has prompted the need for further research into the area of asepsis. The importance of asepsis in PIVC therapy has become an integral part of modern patient care because; almost 60% or more patients admitted to hospital require the insertion of an PIVC.","PeriodicalId":366166,"journal":{"name":"THE GENESIS","volume":"120 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"THE GENESIS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47211/tg.2022.v09i01.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Peripheral intravenous catheters (PIVC) are the most commonly used intravenous device in hospital emergency departments and inpatient units. They are primarily used for therapeutic purposes such as administration of medications, fluids and/or blood products as well as blood sampling. Unsuccessful PIVC first attempts increase pain, and lead to treatment and diagnostic delays. Traditionally, PIVC involves vein and equipment selection before catheterization. Clinicians select peripheral veins based upon vein palpability and visibility, and may use vein stimulation, limb positioning, tourniquets or other techniques to improve first attempt success. There has been an increasing concern among health professional and the general public about HCAI. HCAI is a major cause of morbidity and mortality every year and up to 8.5% of hospitalized patient suffer from HCAI. In a national and multicenter studies reported, it was identified that the prevalence of hospitalized patients who acquired at least one HCAI ranged from 3.5% to 12%. This increasing concern in number of HCAI has prompted the need for further research into the area of asepsis. The importance of asepsis in PIVC therapy has become an integral part of modern patient care because; almost 60% or more patients admitted to hospital require the insertion of an PIVC.
比哈尔邦r.b.纪念医院护理人员外周静脉置管知识与实践自学模块的有效性评估研究
外周静脉导管(PIVC)是医院急诊科和住院部最常用的静脉导管。它们主要用于治疗目的,例如给药、液体和/或血液制品以及血液取样。不成功的PIVC首次尝试会增加疼痛,并导致治疗和诊断延迟。传统上,PIVC需要在置管前选择静脉和设备。临床医生根据静脉的触感和可见性选择外周静脉,并可能使用静脉刺激、肢体定位、止血带或其他技术来提高首次尝试的成功率。卫生专业人员和公众对健康辅助医疗越来越关注。HCAI是每年发病和死亡的主要原因,高达8.5%的住院患者患有HCAI。在一项国家和多中心研究报告中,已确定获得至少一种HCAI的住院患者的患病率在3.5%至12%之间。HCAI数量的增加引起了对无菌领域进一步研究的需要。无菌在PIVC治疗中的重要性已成为现代患者护理的一个组成部分,因为;几乎60%或更多的住院患者需要插入PIVC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信